QTTB Stock Summary and Trading Ideas (Q32 Bio | NASDAQ:QTTB)

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Q32 Bio trades on the NASDAQ stock market under the symbol QTTB.

As of February 19, 2026, QTTB stock price climbed to $4.27 with 57,924 million shares trading.

QTTB has a beta of 0.58, meaning it tends to be less sensitive to market movements. QTTB has a correlation of 0.01 to the broad based SPY ETF.

QTTB has a market cap of $52.54 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that QTTB belongs to (by Net Assets): VTI, VXF.

QTTB has outperformed the market in the last year with a price return of +63.6% while the SPY ETF gained +13.1%. QTTB has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +87.3% and +6.2%, respectively, while the SPY returned +4.0% and -0.2%, respectively.

QTTB support price is $3.78 and resistance is $4.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QTTB shares will trade within this expected range on the day.